Greenlight Capital - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 53 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
Greenlight Capital ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2021$283,000
-74.3%
292,366
-70.8%
0.02%
-72.5%
Q2 2021$1,100,0001,000,0000.07%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Capital CS Group, LLC 75,669$38,0000.04%
Founders Capital Management 18,000$9,0000.01%
Verdence Capital Advisors LLC 58,382$29,0000.00%
WOLFF WIESE MAGANA LLC 10,740$5,0000.00%
TWO SIGMA SECURITIES, LLC 93,669$47,0000.00%
Affinity Capital Advisors, LLC 13,180$7,0000.00%
Tower Research Capital LLC (TRC) 171,928$86,0000.00%
B. Riley Wealth Advisors, Inc. 25,210$13,0000.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 100,000$50,0000.00%
MGO ONE SEVEN LLC 10,615$5,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders